Results 121 to 130 of about 37,401 (251)

Co‐occurring opioid and stimulant use disorder and the relationship to severe maternal morbidity

Pregnancy, Volume 2, Issue 4, July 2026.
Abstract Introduction To evaluate the impact of the use of opioids, stimulants, or both on the rates of various severe maternal morbidity (SMM) events during inpatient delivery‐related hospitalizations among patients with substance use disorder (SUD).
Tucker E. Doiron, Noor Al‐Hammadi, Alexandra R. Schroeder, Niraj R. Chavan   +3 more
wiley   +1 more source

Methamphetamine Use Among Adult Patients Presenting With Acute Coronary Syndrome: A Single-Center Retrospective Cohort Study. [PDF]

J Am Heart Assoc
Zhao SX, Xu W, Jaradeh M, Deluna A, Seng S, Smith CS, Aggarwal M, Crawford MH.   +7 more
europepmc   +1 more source

Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment

The American Journal on Addictions, Volume 35, Issue 4, Page 543-546, July 2026.
Abstract Background and Objectives Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment. Methods A national survey (n = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States.
Erin L. Winstanley, Jane M. Liebschutz, Cristina Murray‐Krezan, Galen E. Switzer, Samantha Nash, Sarah Kawasaki   +5 more
wiley   +1 more source

FAAH rs324420 Polymorphism in People With Opioid and Methamphetamine Use Disorders: Psychological Associations. [PDF]

Brain Behav
Erekli-Arat Ö, Tepe M, Özkan-Kotiloğlu S, Danışman M, Kaya-Akyüzlü D.   +4 more
europepmc   +1 more source

Improving access to direct acting antivirals via a multimodal integrated care program in an addiction medicine clinic

The American Journal on Addictions, Volume 35, Issue 4, Page 534-542, July 2026.
Abstract Background and Objectives Injection drug use is a driver of hepatitis C virus (HCV) transmission, thus integrating HCV care into addiction care is likely necessary for HCV elimination. Here we describe how we integrated HCV care into our addiction medicine (AM) clinic and evaluate its effect on HCV treatment.
Arya Zandvakili, Joseph Rattenni, James Burton, Lakshmi Guduguntla, Marcus Osman, Sayeh Sabbagh, Stephan Arndt, Ben Miskle, Quanhathai Kaewpoowat, Michael Ohl, Andrea Weber, Alison Lynch   +11 more
wiley   +1 more source

Methamphetamine potentiates the use of outcome-specific associations via a hypothalamic-dopamine circuit. [PDF]

Neuron
Hoang IB, Munier JJ, Verghese A, Taira M, Abiero AR, Leake J, Dawson A, Wilcher M, Ganesan K, Ortega ME, Reyes V, Greer Z, Millard SJ, DiFazio LE, Sercander C, Bagley E, Winters B, Izquierdo A, Sharpe MJ.   +18 more
europepmc   +1 more source

What Moves Men to Change? A Mixed‐Methods Study on Facilitators and Barriers of Lifestyle Changes in Men Seeking Fertility Care

Andrology, Volume 14, Issue 5, Page 1220-1230, July 2026.
ABSTRACT Background An unhealthy lifestyle negatively affects male fertility. Despite this, men that are part of an infertile couple often fail to improve their lifestyle and evidence on influencing factors is limited. Objectives To identify facilitators and barriers involved in lifestyle changes of men seeking fertility care and in lifestyle ...
Wiep R. de Ligny, Kathrin Fleischer, Hilde Grens, Didi D. M. Braat, Inger L. Abma, Jan Peter de Bruin   +5 more
wiley   +1 more source

Multimodal MRI Reveals Brain Structural Differences and Executive Dysfunction in Early Methamphetamine Abstinence. [PDF]

Brain Behav
Bristow B, Tayebi M, Condron P, Emsden T, Ngarimu T, Kwon E, McLanachan R, Liu G, Schierding W, McHugh P, Holdsworth S, Mohi W, Newburn G, Scadeng M.   +13 more
europepmc   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, Volume 183, Issue 14, Page 3897-3919, July 2026.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

"I've Never Seen It as a Real Problem": Experiences of Access to Care for People Who Use Methamphetamine. [PDF]

Subst Abuse Rehabil
Peart A, Petukhova R, Sin J, Manning V, Arunogiri S, Lubman DI, Grigg J.   +6 more
europepmc   +1 more source